Search

everythinglearnresearchcommunity

for

Search:↓

A woman had temporary hair loss after scalp surgery, which is a rare but self-healing condition that surgeons should recognize to avoid wrong treatment.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

Hair loss in children is often caused by scalp infections, immune disorders, hair pulling, stress, and requires careful treatment due to emotional effects.

Current treatments for alopecia show no significant long-term benefits.

The conclusion is that pharmacists are important in helping women choose the right skin care treatments.

Loose Anagen Syndrome is a hair condition where hairs can be easily pulled out, mainly affecting young girls, and may improve on its own or with treatment.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Hair-tourniquet syndrome can cause serious toe injuries in infants but can be treated if found early.

The document provided instructions for completing a CME exam on diagnosing and managing hair loss.

Certain gene variations may increase the risk and severity of alopecia areata.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Immune cells affect hair growth and could lead to new hair loss treatments.

A family was found with both Trichorhinophalangeal syndrome and Loose Anagen Syndrome, suggesting a genetic connection.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Early treatment of children's hair loss, which can be caused by various factors, is important due to its emotional impact.

The document concludes that accurate diagnosis and understanding the type of hair disorder are crucial for treating hair loss in children.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

The document concludes that molluscum contagiosum is a common, benign skin infection in children, often healing without scarring.

Minoxidil treatment can reduce hair shedding, increase hair volume, and even change hair color in patients with loose anagen hair syndrome.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.